Jun 28, 2022 / 01:00PM GMT
Christopher J. Hollowood - Freeline Therapeutics Limited - Chairman of the Board
Good afternoon, ladies and gentlemen, and welcome to the Annual General Meeting of Freeline Therapeutics Holdings Plc. As it is now 02:00 p.m. in London, we can start to the proceedings. For those of you that don't know all of us, I'm Chris Hollowood, the Chairman of the company. I'm joined here in Perth by Michael Parini, Chief Executive Officer and a Director of the company; Martin Andrews, a Director of the company; Stephen Diamond, Senior Vice President, General Counsel and Company Secretary; Paul Schneider, Chief Financial Officer; Chip McCorkle, Assistant General Counsel, Corporate and Securities, James Davis, Chief of Staff, Chief Executive Officer.
Joining us by electronic means, we also have Jeffrey Chodakewitz, Julia Gregory, and Amit Nathwani and Colin Love, each are Director of the company; Pamela Foulds, Chief Medical Officer; and Henning Stennicke, Chief Scientific Officer.
This AGM is being conducted as a hybrid meeting, and shareholders are able to attend and participate in the AGM, both in
Freeline Therapeutics Holdings PLC Annual Shareholders Meeting Transcript
Jun 28, 2022
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers